Icon sales jump to €1.3bn for 2014
Dublin-based clinical trials company Icon announced €1.3 billion in sales for 2014.
The provider services to the pharmaceutical, biotechnology and medical device industries said the figure accounted for a 12.5pc jump in demand for its products.
Chief executive Ciaran Murray hailed the results, saying that the growth would allow the firm to “book $1.8 billion (€1.58bn) of new business, to grow our closing backlog by 16pc to $3.6 billion (€3.1bn) and drive revenues by 13pc to over $1.5 billion (€1.5bn).”
“By continuing to improve our operational performance and expand our margins we increased earnings per share by 62pc to $2.87 (€2.52),” he said.
Pre-tax profits for the company jumped to €53 million last year from €34 million in 2013, with fourth quarter sales increasing by 13pc to €343 million.
Fourth quarter gross business wins were €485 million while net business wins were €412 million.
Icon is now guiding sales of €1.4 billion to €1.47 billion this year.